Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative esketamine for prevention of chronic pain after breast cancer surgery
ChiCTR2200066687Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Persistent postsurgical pain (PPSP) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Incidence of chronic pain at 3 months after surgery. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ChiCTR2200066687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066687.